These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28719177)
41. Dopaminergic imaging: clinical utility now and in the future. Walker Z; Rodda J Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S32-40. PubMed ID: 21843378 [TBL] [Abstract][Full Text] [Related]
42. Simulation-based partial volume correction for dopaminergic PET imaging: Impact of segmentation accuracy. Rong Y; Vernaleken I; Winz OH; Goedicke A; Mottaghy FM; Kops ER Z Med Phys; 2015 Sep; 25(3):230-42. PubMed ID: 25172832 [TBL] [Abstract][Full Text] [Related]
43. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355 [TBL] [Abstract][Full Text] [Related]
45. Sugar rush: the early days of molecular imaging. Ell PJ Lancet Oncol; 2008 Apr; 9(4):400. PubMed ID: 18374294 [No Abstract] [Full Text] [Related]
46. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain. Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485 [TBL] [Abstract][Full Text] [Related]
47. Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging. Ko JH; Strafella AP Neuroscientist; 2012 Apr; 18(2):149-68. PubMed ID: 21536838 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein. de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598 [TBL] [Abstract][Full Text] [Related]
58. Structural neuroimaging in neuropsychology: History and contemporary applications. Bigler ED Neuropsychology; 2017 Nov; 31(8):934-953. PubMed ID: 29376671 [TBL] [Abstract][Full Text] [Related]
59. Current status of positron emission tomography radiotracers for serotonin receptors in humans. Zimmer L; Le Bars D J Labelled Comp Radiopharm; 2013; 56(3-4):105-13. PubMed ID: 24285316 [TBL] [Abstract][Full Text] [Related]
60. Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglucose (FDG): applications, limitations and potential. Mercer JR J Pharm Pharm Sci; 2007; 10(2):180-202. PubMed ID: 17706177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]